West Pharmaceutical Services | WST - SCHULD

Aktienkurs
298.37
Täglich Wechseln
0.78 0.26%
Monatlich
19.04%
Jährlich
41.91%
Q2 Prognose
299.61




SCHULD Veränderung Datum
Align Technology USD 114.45M 6.82M 2025-12
Avanos Medical USD 133.7M 3.6M 2025-09
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Cerus USD 84.16M 791K 2024-12
Charles River Laboratories USD 2.63B 157.4M 2025-09
Cooper Companies USD 2.51B 27M 2025-09
Dentsply International USD 2.48B 14M 2025-09
Haemonetics USD 1.22B 54K 2025-09
ICU Medical USD 1.28B 79.88M 2025-12
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
IQVIA Holdings USD 15.72B 767M 2025-12
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Neogen USD 792.93M 396K 2025-09
OraSure Technologies USD 782K 465K 2024-06
Quidel USD 2.84B 51.1M 2025-09
Repligen USD 542.21M 146.65M 2025-12
Solventum Corp USD 7.91B 97M 2025-03
STAAR Surgical USD 39.12M 1.4M 2025-09
Terumo JPY 159.87B 14.97B 2025-09
Utah Medical Products USD 0 0 2022-03
West Pharmaceutical Services USD 202.8M 0 2026-03